The impact of oral GLP-1s on the food and beverage industry summary: A study has found that orfoglipron (Foundayo) can help to maintain weight loss after coming off injectable GLP-1s GLP-1 users could stay appetite-suppressed for significantly longer Big Food should not rely on people cycling on and off GLP-1s There is opportunity for growth if companies focus on nourishment A new study has found that an oral GLP-1 weight-loss medication called orforglipron (Foundayo) can help consumers maintain weight loss after coming off injectable forms of the medication
Are certain symptoms (e.g., cycle length changes, bleeding patterns, PMS severity) more common than others among GLP-1 users
3 That combination matters because appetite, cravings, blood sugar, and energy are not separate issues
Faster heart rate Caffeine stimulates the cardiovascular system, which may cause a temporary rise in heart rate or jitters
Yen-Yi Juo, MD, MPH, and Michael Doney, MD, discuss the potential use of whole-body MRIderived body composition z scores
The weight is starting to come off almost down 10 pounds and cannot wait to get some new Summer clothing